These findings suggest that GWG in early pregnancy may be a potential target for interventions aimed at reducing the risk of HDP.
As a result there has been increased interest in the extent to which gestational weight gain (GWG) may influence HDP and hence provide a potential target for interventions aimed at reducing its risk.
The TNF Superfamily member LIGHT (TNFSF14) has recently emerged as a potential target for therapeutic interventions aiming to halt tissue fibrosis.
Hence, PS has become a potential target for therapeutic strategies aiming at Targeted Drug Delivery.
The miRNA miR-199a-5p may constitute a potential target for clinical approaches aiming to protect hepatocytes in liver disease.
In addition to providing prognostic information, the inflammatory proteins provide a potential target for novel therapies aimed at reversing the inflammatory effects, improving drug handling and reducing toxicity.
So, CRBP-1 can represent a potential target for therapeutic strategies aimed at arresting cancer cell growth and tumour progression by increasing intracellular retinol bioavailability [ 127, 137].
These findings suggest that syntenin deserves further investigation as a potential target for novel therapies aiming to block the metastatic process in this tumor.
On the basis of these findings, we also suggest that the miRNA miR-199a-5p is a potential target for clinical approaches aiming to protect hepatocytes in liver disease.
These exciting findings suggest CRK as a potential target for future systemic agents aimed at treating human bladder cancers.
